0001948469-22-000001.txt : 20220930 0001948469-22-000001.hdr.sgml : 20220930 20220929180549 ACCESSION NUMBER: 0001948469-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220930 DATE AS OF CHANGE: 20220929 EFFECTIVENESS DATE: 20220930 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diceros Therapeutics, Inc. CENTRAL INDEX KEY: 0001948469 IRS NUMBER: 874579261 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-460347 FILM NUMBER: 221281715 BUSINESS ADDRESS: STREET 1: 275 GROVE STREET, 2-400 CITY: NEWTON STATE: MA ZIP: 02466 BUSINESS PHONE: 617-663-5784 MAIL ADDRESS: STREET 1: 275 GROVE STREET, 2-400 CITY: NEWTON STATE: MA ZIP: 02466 D 1 primary_doc.xml X0708 D LIVE 0001948469 Diceros Therapeutics, Inc. 275 GROVE STREET, Suite 2-400 NEWTON MA MASSACHUSETTS 02466 617-663-5784 DELAWARE None None Corporation true 2022 Stephen R. Seiler c/o Diceros Therapeutics, Inc. 275 Grove Street, Suite 2-400 Newton MA MASSACHUSETTS 02466 Executive Officer Director Jonathan Fleming c/o Diceros Therapeutics, Inc. 275 Grove Street, Suite 2-400 Newton MA MASSACHUSETTS 02466 Director Biotechnology Decline to Disclose 06b false 2022-09-19 true true false 0 16699979 6679992 10019987 false 13 0 0 195911 false Diceros Therapeutics, Inc. /s/ Stephen R. Seiler Stephen R. Seiler CEO 2022-09-26